Anteotech Ltd
ASX:ADO

Watchlist Manager
Anteotech Ltd Logo
Anteotech Ltd
ASX:ADO
Watchlist
Price: 0.011 AUD -8.33%
Market Cap: AU$32.7m

Anteotech Ltd
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Anteotech Ltd
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Anteotech Ltd
ASX:ADO
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genetic Technologies Ltd
ASX:GTG
Intangible Assets
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proteomics International Laboratories Ltd
ASX:PIQ
Intangible Assets
AU$1k
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Intangible Assets
AU$26.9m
CAGR 3-Years
-37%
CAGR 5-Years
104%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Intangible Assets
AU$1.9m
CAGR 3-Years
470%
CAGR 5-Years
152%
CAGR 10-Years
16%
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Intangible Assets
AU$28.1k
CAGR 3-Years
14%
CAGR 5-Years
88%
CAGR 10-Years
N/A
No Stocks Found

Anteotech Ltd
Glance View

AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

ADO Intrinsic Value
LOCKED
Unlock

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett